Shingles Vaccine Uptake Lags Despite Effectiveness and Expanded Program

Millions of eligible adults in the UK are not taking up the offer of a free shingles vaccine, raising concerns about potential outbreaks of the painful condition. Recent data from the UK Health Security Agency (UKHSA) reveals that less than half of those eligible have received their first dose of the Shingrix vaccine.

Uptake Rates Remain Below 50%

According to the latest figures, only 42.1% of individuals turning 66 – who became eligible after their 65th birthday – had received their first dose of Shingrix by October 2025. Among those turning 71, who were eligible from age 70, coverage stood at 53.5% [1]. These figures highlight a significant gap in vaccine coverage despite the proven benefits of the Shingrix vaccine.

The Shingrix for All Programme

The Shingrix for All programme, launched on September 1, 2023, offers two doses of the Shingrix vaccine to individuals turning 65 or 70. It is also available to severely immunosuppressed adults aged 18 and over. The vaccine is administered year-round, with eligibility triggered at ages 65 and 70 [4].

Why is Shingles Vaccination Important?

Shingles, caused by the reactivation of the chickenpox virus, can cause a painful rash and lasting nerve damage. The condition can have debilitating effects for months, even after the rash has subsided. Two doses of the Shingrix vaccine are highly effective in preventing shingles and its serious complications [4].

Expanding the Vaccination Programme

NHS England (NHSE) is actively working to expand the shingles vaccination programme over the next decade. Updated technical guidance for GP practices was published last month, outlining eligible cohorts and plans for future expansion [3]. Adults aged 70 to 80 who have not yet been vaccinated are also encouraged to catch up.

Potential Link to Reduced Dementia Risk

Emerging research suggests that the Shingrix vaccine may offer additional benefits beyond shingles prevention. A 2024 University of Oxford study indicated a 17% reduction in dementia diagnoses among individuals who received the Shingrix vaccine [3].

Call to Action

Dr. Julie Yates, Deputy Director for Immunisation Programmes at UKHSA, urges eligible individuals to book their shingles vaccine appointment. “We understand people are busy, and it can be easy to put things off, but this is a vaccine that can make a real difference to your quality of life,” she stated [4]. Caroline Temmink, Director of Vaccinations at NHS England, emphasized the potential dangers of shingles for older adults and those with weakened immune systems.

Eligible individuals can check their eligibility and book a jab through their GP or at NHS.uk.